Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Novalon signs research agreement with Millennium

Nov. 16, 1998

S-18127 characterized as a selective, structurally novel 5-HT1B/1D receptor antagonist

Nov. 12, 1998

Sangamo enters agreement with Zeneca for identification of novel gene targets

Nov. 10, 1998

MitoKor and Pfizer to collaborate on mitochondrial targets for neurodegenerative diseases

Nov. 10, 1998

Corixa invests in, works with ImmGenics to develop high-potency monoclonal antibodies

Nov. 9, 1998

Dutch research group focuses attention on adenosine A3 receptor ligands

Nov. 5, 1998

Step taken toward European protection for AltaRex's fundamental technology platform

Nov. 5, 1998

GenVec receives expanded patent coverage in field of gene therapy

Nov. 4, 1998

New agreement between Pharmacopeia and Schering-Plough expands R&D collaboration

Nov. 4, 1998

Aastrom awarded second NIH grant to develop production system for UCB stem cells

Nov. 3, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...